| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |